发明名称 |
CANCER STEM CELL-TARGETED CANCER THERAPY |
摘要 |
<p>The invention relates to an alkylating agent for use in a method of reducing cancer stem cells in patient that has been diagnosed with cancer, wherein said patient is administered said alkylating agent at a dose less than the maximum tolerated dose (MTD), and wherein the cancer stem cell population in said patient is monitored to determine whether said agent has resulted in a reduction of cancer stem cell in said patient.</p> |
申请公布号 |
HK1201724(A1) |
申请公布日期 |
2015.09.11 |
申请号 |
HK20150102215 |
申请日期 |
2015.03.04 |
申请人 |
STEMLINE THERAPEUTICS INC. |
发明人 |
CIRRITO, THOMAS, P.;BERGSTEIN, IVAN |
分类号 |
A61K;A61P;G01N |
主分类号 |
A61K |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|